135 related articles for article (PubMed ID: 367582)
1. Historical background and aspects of the mechanism of leukocyte adherence inhibition.
Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):558-63. PubMed ID: 367582
[TBL] [Abstract][Full Text] [Related]
2. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
Raina S; Russo AJ; Jenkins D; Goldrosen MH
Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
[TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction.
Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Holyoke ED
Cancer Res; 1979 Feb; 39(2 Pt 2):587-92. PubMed ID: 367585
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
[TBL] [Abstract][Full Text] [Related]
5. The cellular mechanism of leukocyte adherence inhibition.
Koppi TA; Maluish AE; Halliday WJ
J Immunol; 1979 Nov; 123(5):2255-60. PubMed ID: 314958
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the mechanism of the leukocyte adherence inhibition test.
Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
[TBL] [Abstract][Full Text] [Related]
7. Micro-leukocyte adherence inhibition. I. Cellular basis of the mechanism of reactivity.
Russo AJ; Howell JH; Leveson SH; Holyoke ED; Goldrosen MH
J Immunol; 1978 Nov; 121(5):1914-9. PubMed ID: 81856
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
Halliday WJ; Maluish AE; Stephenson PM; Davis NC
Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
[TBL] [Abstract][Full Text] [Related]
9. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
Rudczynski AB; Dyer CA; Mortensen RF
Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
[No Abstract] [Full Text] [Related]
10. Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.
Noonan FP; Halliday WJ; Wall DR; Clunie GJ
Cancer Res; 1977 Aug; 37(8 Pt 1):2473-80. PubMed ID: 872076
[TBL] [Abstract][Full Text] [Related]
11. The role of leukocyte subpopulations in the indirect leukocyte adherence inhibition assay in the mammary tumor virus system.
Creemers P
Eur J Immunol; 1977 Jan; 7(1):48-53. PubMed ID: 191259
[TBL] [Abstract][Full Text] [Related]
12. Immunological mechanisms of tube leukocyte adherence inhibition.
Thomson DM; Grosser N
Cancer Res; 1979 Feb; 39(2 Pt 2):576-81. PubMed ID: 83912
[No Abstract] [Full Text] [Related]
13. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
14. Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
Leveson SH; Howell JH; Paolini NS; Tan MH; Holyoke ED; Goldrosen MH
Cancer Res; 1979 Feb; 39(2 Pt 2):582-6. PubMed ID: 367584
[TBL] [Abstract][Full Text] [Related]
15. Application of the indirect tube LAI assay in the study of cell-mediated immunity in rats immunized with B77 tumor cells.
Kalafut F; Hung PM; Novotná L; Klobusická M
Neoplasma; 1980; 27(5):525-31. PubMed ID: 7015159
[TBL] [Abstract][Full Text] [Related]
16. Humoral leukocyte adherence inhibition (H-LAI) follow-up trials on malignant process in mice.
Kubasova T; Pázmány T; Horváth M; Pál K; Köteles GJ
Neoplasma; 1991; 38(1):63-8. PubMed ID: 2011211
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
18. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid source and target of murine leukocyte adherence inhibition factor (LAIF).
Myers WL; O'Keefe ML; Gregory S
Immunol Lett; 1981 Nov; 3(5):277-82. PubMed ID: 6976930
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
Halliday WJ; Koppi TA; McKenzie IF
J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]